Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as ...

Eli Lilly is broadening its direct-to-consumer approach by partnering with a digital health company, Noom, which is focused ...

This integration evolves Noom’s comprehensive approach to weight management by enabling a streamlined solution for members ...

Move over, chips and cookies – snacking is getting a GLP-1-era makeover. A recent Cornell University and Numerator study found households with at least one user of GLP-1 – medications like ...

Compounding pharmacies have been allowed to essentially make a cheaper version of Eli Lilly's Zepbound, but they have to stop Wednesday. That has... Patients scramble as cheaper obesity drug ...

They've each lost about 20 pounds in six weeks. But the Agars, who live in Minnesota, aren't taking Eli Lilly's Zepbound; their insurance doesn't cover it. They're taking a cheaper alternative ...

"No, never," her husband, Jackson, says. They've each lost about 20 pounds in six weeks. But the Agars, who live in Minnesota, aren't taking Eli Lilly's Zepbound; their insurance doesn't cover it.

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are now. By Rebecca Robbins It’s easy to make a medical case for ...